Havells India Stock Performance – 20 Oct 2026
- Price movement (24 h ending 05:07 PM CET, 20 Oct 2026): down 1.63 %.
- Current trading price: INR 1,102.7.
- Shares outstanding: 627.6 million.
- Market capitalisation: INR 692 billion.
- Volume traded in last 24 h: INR 346.6 million.
- Month‑end change (last month): down 0.04 %.
- 200‑day simple moving average: INR 1,241.05.
- 52‑week high: INR 1,516.6 (30 Oct 2025).
- 52‑week low: INR 1,015.1 (30 Sep 2026).
Technical Context
- The share price has recently crossed key support levels near INR 1,000, indicating a potential exit from an oversold phase.
- Trading remains below long‑term moving averages, suggesting that a sustained upward trajectory is required for a full reversal.
- A decline below critical support could push the price toward lower zones.
Market Environment
- Large‑cap stocks are rebounding, driven by positive earnings from banking and IT sectors.
- Rising oil prices and geopolitical tensions persist as potential headwinds.
Analyst Outlook
- Analysts view the current price action as an early sign of recovery.
- Moderate upside potential is noted, pending confirmation of bullish momentum.
- Risks include a potential pullback below support levels.
Performance of Related Stocks – 19 Oct 2026 (Last 24 h)
| Symbol | Change | Current Price (INR) | Market Capitalisation (INR bn) | P/E Ratio |
|---|---|---|---|---|
| MAZDOCK.NS | –0.62 % | 2,052 | 827.7 | 31.97 |
| BHARTIHEXA.NS | –1.73 % | 1,632.6 | 808 | 43.19 |
| MAXHEALTH.NS | –1.89 % | 830 | 807.8 | 55.83 |
| DIXON.NS | –1.94 % | 12,100 | 761.6 | 37.5 |
| SHREECEM.NS | +0.65 % | 22,290 | 810.4 | 49.1 |
Notable Events – Max Healthcare Institute
On 19 Oct 2026, Max Healthcare Institute Limited announced that shareholders approved four special resolutions via remote e‑voting:
- Launch of a 2026 Performance‑Linked Restricted Stock Unit scheme for employees.
- Similar grant for subsidiary employees.
- Approval of remuneration for the chairman and managing director.
- Amendment to the main objects clause of the memorandum.
All resolutions received decisive support; the company disclosed the structure of the new stock‑unit scheme, including the number of shares that may be issued and the exercise price aligned with the face value. No adverse developments or market‑impact statements were included in the disclosures.
